CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.040
-0.010 (-0.95%)
At close: Mar 17, 2026, 4:00 PM EDT
0.9901
-0.0500 (-4.80%)
Pre-market: Mar 18, 2026, 8:02 AM EDT
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $12 million as of March 18, 2026. Its market cap has decreased by -62.86% in one year.
Market Cap
12.00M
Enterprise Value
10.14M
1-Year Change
-62.86%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $12.00M, a decrease of -73.98%. That is a compound annual growth rate of -36.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 12.00M | -22.10% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quoin Pharmaceuticals | 12.96M |
| Kairos Pharma | 12.62M |
| IO Biotech | 12.57M |
| Purple Biotech | 12.39M |
| Soligenix | 12.36M |
| NewcelX | 12.08M |
| OSR Holdings | 11.41M |
| BioLineRx | 11.17M |